Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review | Zendy

Lucas Vieira dos Santos | Zendy; Fabrício Henrique Pereira De Souza | Zendy; André T. Brunetto | Zendy; André Deeke Sasse | Zendy; João Paulo da Silveira Nogueira Lima | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review

Author(s) -

Lucas Vieira dos Santos,

Fabrício Henrique Pereira De Souza,

André T. Brunetto,

André Deeke Sasse,

João Paulo da Silveira Nogueira Lima

Publication year - 2012

Publication title -

jnci journal of the national cancer institute

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.797

H-Index - 356

eISSN - 1460-2105

pISSN - 0027-8874

DOI - 10.1093/jnci/djs335

Subject(s) - antiemetic , nausea , vomiting , chemotherapy induced nausea and vomiting , aprepitant , medicine , tachykinin receptor 1 , chemotherapy , nk1 receptor antagonist , pharmacology , receptor , substance p , neuropeptide

The addition of neurokinin-1 receptor (NK1R) antagonists to antiemetic regimens has substantially reduced chemotherapy-induced nausea and vomiting (CINV). We sought to systematically review the overall impact of NK1R antagonists on CINV prevention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research